- Ubaq is headquartered in Paris, France
- Extens invested in Clardian in 2021
- Extens is a Paris, France-based digital health investment fund
Clardian, backed by Extens, has merged with Qairn to form Ubaq, a company that assists health sector industries digitise regulatory processes.
No financial details of the transaction were disclosed.
Ubaq is based in Paris, France. The company currently has around 50 employees.
Ubaq will support pharmaceutical companies and medical device manufacturers digitise via a SaaS software suite that will simplify the application of regulatory framework, according to a release.
Extens invested in Clardian in 2021.
“These assets should enable Ubaq to establish itself as a major European player in pharmtech by putting innovation at the service of the healthcare players,” said Morgane Decultieux, associate at Extens and a member of Ubaq board.
Clardian is a company in the software market that focuses on compliance and optimisation of regulatory processes for the healthcare industry. The company is based in Paris, France.
Qairn is a technology company based in Paris, France.
Extens is a Paris, France-based digital health investment fund. The firm acts as a growth investor, mainly in France and Western Europe, by injecting up to €15 million into SMEs that generate over €3 million in revenue and are EBITDA positive.